LINC02729

Across TCGA pan-cancer cohorts, LINC02729 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated LINC02729 data layer.

The strongest signal is observed in thymoma (THYM), where higher LINC02729 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02729 expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

THYM, READ, and LIHC are the cancer types where LINC02729 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	All	0.107	0.872	<.001	18	view →
READ	DFS	Tertile	All	0.112	0.845	.001	18	view →
LIHC	DFS	Tertile	II,III,IV	0.053	0.427	.003	18	view →
UCS	DFS	Quartile	II,III,IV	0.785	0.335	.003	12	view →
HNSC	DFS	Tertile	III,IV	0.204	0.508	.029	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

LINC02729–THYM (DFS)

Open the THYM breakdown →